The 72-year-oldsurvived almost a decade of rape involving dozens of men as she was unknowingly drugged by her ex-husband, ...
LGU action reinforces the push for a stronger, nationwide DOH program to meet WHO cervical cancer elimination goals by 2030. Santo Tomas City in Batangas has taken bold steps in its cervical cancer ...
Asianet Newsable on MSN
Scientists unveil HPV-DeepSeek, a test that spots cancer 10 years early
DeepSeek, a blood test that detects HPV-linked head and neck cancers up to 10 years early with 99% accuracy. The breakthrough ...
DeepSeek, a blood test that can detect HPV-linked head and neck cancers nearly a decade before diagnosis. By finding viral DNA in the bloodstream, the test achieved 99% sensitivity and specificity.
Bizcommunity on MSN
Cervical cancer | Profmed’s Dr Moratwe Masima on prioritising prevention
September marked Cervical Cancer Awareness Month in South Africa. Research suggests that cervical cancer ranks as the fourth leading cancer type in the world for women. Most of the cervical cancer ...
Health officials in Yilo Krobo say some parents are stopping their daughters from receiving the free Human Papillomavirus ...
New research using genetic data has uncovered causal links between common viral infections and several psychiatric disorders.
Shares of Bicara Therapeutics rose sharply in premarket trading Monday after the clinical-stage biopharmaceutical company won U.S. Food and Drug Administration breakthrough-therapy designation for its ...
Designation supported by results from multiple dose cohorts from the Phase 1/1b trial of ficerafusp alfa in 1L HPV-negative R/M HNSCCBOSTON, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback